An observational study demonstrating the efficacy of interleukin-1 antagonist (anakinra) in critically-ill patients with hemophagocytic lymphohistiocytosis

An observational study demonstrating the efficacy of interleukin-1 antagonist (anakinra) in critically-ill patients with hemophagocytic lymphohistiocytosis

Secondary hemophagocytic hymphohistiocytosis (HLH) is an underrecognized cause of multisystem organ failure (MSOF) in critically ill adults, associated with high mortality even when recommended etoposide-based treatments are administered. Anakinra, an interleukin-1 receptor antagonist, has shown pro...

Full description

Bibliographic Details
Main Authors: Henry K, Raschke RA
Format: Article
Language:English
Published: Arizona Thoracic Society 2019-06-01
Series:Southwest Journal of Pulmonary and Critical Care
Subjects:
H score
HLH
adult
anakinra
fungal infection
hemophagocytic lymphohistiocytosis
interleukin 1
multisystem organ failure
secondary
survival
Online Access:http://www.swjpcc.com/critical-care/2019/6/28/an-observational-study-demonstrating-the-efficacy-of-interle.html

Internet

http://www.swjpcc.com/critical-care/2019/6/28/an-observational-study-demonstrating-the-efficacy-of-interle.html

Similar Items